Questions really need to be asked why the market acceptance of this technology is so lackluster, even after inclusion in the guidelines. I wasn't expecting much from this result, but 13 unit sales in the US way below my already low expectations. Will be fascinating to hear how the "new team" think they are going to get sales rolling.
- Forums
- ASX - By Stock
- IPD
- Ann: Quarterly Activities Report and Appendix 4C - Dec-23 Qtr
Ann: Quarterly Activities Report and Appendix 4C - Dec-23 Qtr, page-25
Featured News
Add IPD (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.3¢ |
Change
-0.001(1.85%) |
Mkt cap ! $107.2M |
Open | High | Low | Value | Volume |
5.4¢ | 5.4¢ | 5.2¢ | $68.49K | 1.292M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 400000 | 5.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.3¢ | 14094 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 400000 | 0.052 |
1 | 500000 | 0.051 |
5 | 190000 | 0.050 |
1 | 61000 | 0.049 |
1 | 27812 | 0.048 |
Price($) | Vol. | No. |
---|---|---|
0.053 | 14094 | 1 |
0.054 | 100000 | 1 |
0.055 | 332498 | 2 |
0.056 | 250000 | 1 |
0.058 | 7842 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
IPD (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online